CELL THERAPY CATAPULT LIMITED
Company Information
- Company Number
- 07964711
- Registered Address
- 12th Floor Tower Wing B, Guys Hospital, London, SE1 9RT
- Status
- Active
- Employee Count
- 407
- Turnover
- £59,114,000
- EBITDA
- £12,935,000
Additional Details
- Website
- https://ct.catapult.org.uk
- Company Type
- Private company limited by guarantee without share capital
- Incorporated On
- 24 February 2012
- Nature of Business
- 74909 - Other professional, scientific and technical activities not elsewhere classified
- Industries
- Life Sciences And Medical Technology
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2025 - 30 Sept 2025 | 29 Oct 2025 | 16 | 85% | 13% | 2% | 5% |
| 01 Oct 2023 - 31 Mar 2024 | 30 Apr 2024 | 13 | 92% | 6% | 2% | 2% |
| 01 Apr 2023 - 30 Sept 2023 | 31 Oct 2023 | 14 | 89% | 8% | 3% | 1% |
| 01 Oct 2022 - 31 Mar 2023 | 02 May 2023 | 17 | 87% | 10% | 3% | 2% |
| 01 Apr 2022 - 30 Sept 2022 | 01 Nov 2022 | 16 | 89% | 9% | 2% | 2% |
| 01 Apr 2021 - 30 Sept 2021 | 03 Nov 2021 | 15 | 91% | 7% | 2% | 1% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Invoices are paid on standard terms of 30 days
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
30
Dispute Resolution Process
Suppliers have a generic accounts payable email address to send in their queries. This email address is monitored and escalated to relevant employees and managers as appropriate. Suppliers will receive a response to their email with in 3-5 working days depending on the query.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
Cell Therapy Catapult Limited is a UK-based company that specializes in developing and commercializing cell and gene therapies. They are committed to advancing the field of regenerative medicine and improving patient outcomes through innovative technologies.
The company's sustainability program focuses on reducing their environmental impact through initiatives such as reducing waste, increasing energy efficiency, and promoting sustainable transportation. They also prioritize social responsibility by supporting diversity, inclusion, and ethical business practices.
Cell Therapy Catapult offers a range of products and services to support the development and translation of cell and gene therapies. This includes cell and gene therapy manufacturing, process development, regulatory support, and training programs.
The key people at Cell Therapy Catapult include CEO Matthew Durdy, who has over 20 years of experience in the biopharmaceutical industry, and Chairwoman Dr. Fiona Marshall, a renowned expert in the field of drug discovery and development.
Their website, www.ct.catapult.org.uk, provides comprehensive information about their company, services, and latest news and events. Their registered office address is 12th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT.
In summary, Cell Therapy Catapult Limited is a leading company in the field of regenerative medicine, with a strong focus on sustainability and social responsibility. Their range of services and experienced team make them a valuable partner for advancing cell and gene therapies.
